First Time Loading...

Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 5.27 HKD 0.38% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one Shandong Weigao Group Medical Polymer Co Ltd stock under the Base Case scenario is 10.57 HKD. Compared to the current market price of 5.27 HKD, Shandong Weigao Group Medical Polymer Co Ltd is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
10.57 HKD
Undervaluation 50%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
95
vs Industry
55
Median 3Y
3.1
Median 5Y
3.4
Industry
2.4
Forward
1.6
More Details
11.2
P/E
P/E
Price to Earnings
11.2
vs History
95
vs Industry
39
Median 3Y
16.8
Median 5Y
18.4
Industry
23.4
Forward
10.1
More Details
10.2
P/OCF
P/OCF
Price to OCF
10.2
vs History
92
vs Industry
35
Median 3Y
15.2
Median 5Y
15.5
Industry
15.5
More Details
10.2
P/FCFE
P/FCFE
Price to FCFE
10.2
vs History
90
vs Industry
34
Median 3Y
16.6
Median 5Y
19.3
Industry
23.2
More Details
1
P/B
P/B
Price to Book Value
1
vs History
95
vs Industry
63
Median 3Y
2
Median 5Y
2.2
Industry
2.3
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
95
vs Industry
60
Median 3Y
2.8
Median 5Y
3.4
Industry
2.5
Forward
1.4
More Details
2.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.8
vs History
95
vs Industry
62
Median 3Y
5.1
Median 5Y
5.6
Industry
5.3
More Details
7.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.3
vs History
92
vs Industry
41
Median 3Y
11.7
Median 5Y
12.1
Industry
12.6
Forward
5.6
More Details
7.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
7.3
vs History
95
vs Industry
43
Median 3Y
11.9
Median 5Y
14.6
Industry
17.2
Forward
6.7
More Details
8.5
EV/OCF
EV/OCF
Enterprise Value to OCF
8.5
vs History
95
vs Industry
41
Median 3Y
13.9
Median 5Y
15.2
Industry
15.3
More Details
8.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.5
vs History
95
vs Industry
37
Median 3Y
14.9
Median 5Y
16.4
Industry
19.8
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
95
vs Industry
68
Median 3Y
1.6
Median 5Y
1.8
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Shandong Weigao Group Medical Polymer Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
24.1B HKD 1.7 11.2 7.3 7.3
JP
Hoya Corp
TSE:7741
6.4T JPY 8.5 38.3 23.2 28.7
CH
Alcon AG
SIX:ALC
35.6B CHF 4.2 40.4 18 36.6
DK
Coloplast A/S
CSE:COLO B
193.3B DKK 7.7 39.7 26.1 30.3
US
Align Technology Inc
NASDAQ:ALGN
21.7B USD 5.5 46.9 25.8 31.3
US
Cooper Companies Inc
NYSE:COO
18B USD 4.9 61.9 22.7 38.5
KR
HLB Inc
KOSDAQ:028300
13.3T KRW 310 -70.3 -114.6 -105.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
55.6B CNY 14.1 33.6 29.2 29.2
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 51.1 46.8 50.9
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD 1.5 -44.4 11.5 24.7
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.2B USD 4 15.8 11.6 13.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.